Oncocyte Corp Annual Cost of Revenue in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Oncocyte Corp quarterly/annual Cost of Revenue history and growth rate from 2020 to 2023.
  • Oncocyte Corp Cost of Revenue for the quarter ending September 30, 2024 was $43K, a 73% decline year-over-year.
  • Oncocyte Corp Cost of Revenue for the twelve months ending September 30, 2024 was $736K, a 15.5% decline year-over-year.
  • Oncocyte Corp annual Cost of Revenue for 2023 was $1M, a 13.9% increase from 2022.
  • Oncocyte Corp annual Cost of Revenue for 2022 was $880K, a 26.3% increase from 2021.
  • Oncocyte Corp annual Cost of Revenue for 2021 was $697K, a 62.4% decline from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1M +$122K +13.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-16
2022 $880K +$183K +26.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
2021 $697K -$1.16M -62.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-12
2020 $1.86M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.